Canaccord cuts Viking Therapeutic stock price target on obesity pricing
Canaccord cuts Viking Therapeutic stock price target on obesity pricing Investing.com
Read the full story on Investing.com → Opens the original article on news.google.comSummary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.